PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C0341439|chronic liver disease |
| Sentences | 14 |
| PubMedID- 25339354 | The 13c-galactose bt has also been used to assess progressive decline in liver mass function in patients with chronic liver disease due to hepatitis c virus (hcv) infection . |
| PubMedID- 25030555 | Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c. |
| PubMedID- 22359532 | Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease. |
| PubMedID- 20388084 | Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol. |
| PubMedID- 22419479 | We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology. |
| PubMedID- 23914225 | In patients with chronic liver disease due to hepatitis c virus infection, adiponectin was positively correlated with hepatic inflammation, and adiponectin receptors were differentially regulated in the setting of hepatic insulin resistance (12). |
| PubMedID- 23763386 | Aim: in chronic liver disease associated with hepatitis c virus (hcv), a low platelet count is a major obstacle in carrying out interferon (ifn) treatment. |
| PubMedID- 26502286 | In contrast, zinc has antioxidant properties, and its level in chronic liver disease due to hepatitis c is inversely correlated with viral load . |
| PubMedID- 24815847 | chronic liver disease due to hepatitis c affects a large number of hiv-infected patients in latin america and currently poses important challenges for the health systems in the region. |
| PubMedID- 21258658 | Hepatitis b and hepatitis c are important causes of chronic liver disease globally. |
| PubMedID- 23497336 | Eltrombopag, an oral, nonpeptide, thrombopoietin receptor agonist, increases platelet counts in adult patients with chronic immune thrombocytopenia (itp) and chronic liver disease due to hepatitis c virus infection . |
| PubMedID- 21294867 | The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups. |
| PubMedID- 22505377 | Background/aims: hepatitis c virus leads to chronic liver disease, cirrhosis and hepatocellular cancer. |
| PubMedID- 25400432 | chronic liver disease including hepatitis c virus (hcv) infection is one of the main cause for the development of hepatic angiogenesis and thereby plays a critical role in the modulation of hepatic angiogenesis that finally leads to hepatocellular carcinoma progression and invasion. |
Page: 1